mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.8 |